Ga-66 labeled somatostatin analogue DOTA-DPhe1-Tyr3-octreotide as a potential agent for positron emission tomography imaging and receptor mediated internal radiotherapy of somatostatin receptor positive tumors

Nuclear Medicine and Biology

Volumn 29, Issue 2, 2002, Pages 147-157

  Ugur, Ömer ^a,c   Kothari, Paresh J ^a   Finn, Ronald D ^a   Zanzonico, Pat ^a   Ruan, Shutian ^a   Guenther, Ilonka ^a   Maecke, Helmut R ^b   Larson, Steven M ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

^c HACETTEPE UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETIC ACID; GALLIUM; OCTREOTIDE[1 DEXTRO PHENYLALANINE 3 TYROSINE 1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETIC ACID] GA 66; RADIOISOTOPE; SOMATOSTATIN DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; BONE MARROW; CONTROLLED STUDY; DOSIMETRY; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG TARGETING; DRUG UPTAKE; ISOTOPE LABELING; KIDNEY; LIGAND BINDING; NONHUMAN; PANCREAS TUMOR; POSITRON EMISSION TOMOGRAPHY; RADIOASSAY; RADIOCHEMISTRY; RAT;

ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; GALLIUM RADIOISOTOPES; MICE; OCTREOTIDE; PANCREATIC NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RATS; RECEPTORS, SOMATOSTATIN; TUMOR CELLS, CULTURED;

EID: 0036159457     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-8051(01)00290-6     Document Type: Article

References (34)

1. D-lysine reduction of indium-111 octreotide and yttrium-90 octreotide renal uptake
2. Peptide radiopharmaceuticals in nuclear medicine
3. 67Ga
4. Binding properties of somatostatin receptor subtypes
5. Complete tumor ablation with iodine-131 radiolabeled disialoganglioside GD2 specific monoclonal antibody against neuroblastoma xenografted in nude mice
6. Molecular and pharmacological characterization of somatostatin receptor subtypes in adrenal, extraadrenal, and malignant pheochromocytomas
7. The use of radionuclides for tumor therapy
8. Distribution and characterisation of somatostatin receptor mRNA and binding sites in the brain and periphery
9. Differential regulation of somatostatin type 2 receptor (sst 2) expression in AR4-2J tumor cells implanted into mice during octreotide therapy
10. A microplate binding assay for the somatostatin type-2 receptor (SSTR2)
11. Preclinical comparison in AR4-2J tumor bearing mice of four radiolabeled 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid somatostatin analogs for tumor diagnosis and internal radiotherapy
12. 66Ga as an isotope for PET imaging and quantification
13. Amino acid infusion blocks renal tubular uptake of an indium-labelled somatostatin analogue
14. 3-Octreotide (DOTATOC): First results in patients with meningiomas
15. Radiometal-labelled macrocyclic chelator derivatised somatostatin analogue with superb tumor targeting properties and potential for receptor mediated internal radiotherapy
16. Receptor targeting for tumor localization and therapy with radiopeptides
17. Quantitative [Ga-68]-DOTATOC SMS receptor PET and planar [Ga-67]-DOTATOC SMS receptor scintigraphy in the pre-therapeutical dosimetry of neuroendocrine tumors
18. Radiolabeled somatostatin analogue(s) for peptide receptor scintigraphy and radionuclide therapy
19. Peptide receptor imaging and therapy
20. Radioimmunology: Imaging and therapy
21. Measurement of p-glycoprotein expression in multidrug-resistant human neuroblastoma cell lines using self-competitive binding assay
22. Comparative dosimetry of copper-64 and yttrium-90 labeled somatostatin analogs in a tumor-bearing rat model
23. A new generator for ionic gallium-68
24. Yttrium-90-labelled somatostatin-analogue for cancer treatment
25. Yttrium-90 DOTATOC: First clinical results
26. 3-octreotide
27. Quantitative imaging of yttrium-86 with PET: The ocurance and correction of anomalous apparent activity in high density regions
28. Radiolabeled antibody therapy of B-cell lymphoma with autologous bone marrow support
29. High affinity binding sites for a somatostatin-28 analog in rat brain
30. 90Y-labelled analogue
31. OctreoTher: Ongoing early clinical development of a somatostatin-receptor-targeted radionuclide antineoplastic therapy
32. 90Y-SMT 487) eradicates experimental rat pancreatic CA 20948 tumors
33. Comparison of the targeting characteristics of various radioimmunoconjugates for radioimmunotherapy of neuroblastoma: Dosimetry calculations incorporating cross-organ beta doses